View Press Releases
-
Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Industry Conversations
PHILADELPHIA, PA - Nov 27, 2019 - Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO)
Nov 27, 2019
-
Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever
LONDON, UK - Nov 26, 2019 - Prokarium, a private biotechnology company developing vaccines against infectious diseases and immunotherapy for solid tumors, has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with Entervax, a bivalent vaccine against enteric fever
Nov 25, 2019
-
SAKOR Technologies Announces Dynamometer Line for Testing Electric Motor Efficiency to Meet International Environmental Standards
OWOSSO, MI, UNITED STATES - Nov 25, 2019 - For Immediate ReleaseContact: Judi Handel McNeil, Gray & Rice 617-367-0100 ext
Nov 25, 2019
-
Debiopharm Implements Dotmatics to Improve Data-Driven Decision-Making
BISHOP'S STORTFORD, UNITED KINGDOM - Nov 25, 2019 - Debiopharm International SA, the drug development company focused on oncology and infectious diseases, has implemented tools from Dotmatics, a leading provider of scientific informatics solutions and services, to re-engineer its data management processes to support its continuous growth
Nov 25, 2019
-
Potential findings on whole genome sequencing for cancer treatment was made
SHIRLEY, NY, UNITED STATES - Nov 25, 2019 - In recent years, individualized treatments will benefit more cancer patients as the time and cost of whole genome sequencing decreases
Nov 24, 2019
-
Spring Bank Announces Dosing of Patients in Phase 1 Clinical Trial of IV-Administered STING Agonist, SB 11285
HOPKINTON, MA, UNITED STATES - Nov 20, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has initiated dosing patients in a Phase 1 trial of SB 11285, the companys intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist
Nov 21, 2019
-
Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution
PRINCETON, NJ - Nov 21, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the availability of PK Submit, a technology solution for automating the creation of PK Clinical Data Interchange Standards Consortium (CDISC) domains during Non-Compartmental Analysis (NCA)
Nov 21, 2019
-
Elsevier joins forces with Food and Drug Administration to build predictive drug-induced liver injury AI algorithm
NEW YORK, NY - Nov 21, 2019 - Elsevier, a global information analytics business specializing in science and health, has entered into a Collaborative Research and Development Agreement (CRADA) with the National Center for Toxicological Research (NCTR) at the Food and Drug Administration (FDA)
Nov 21, 2019
-
Creative Proteomics Has Made Targeted Metabolomics Service More Perfect
SHIRLEY, NY - Nov 21, 2019 - November 21, 2019, as an integrated company and leading supplier in the field of proteomics, metabolomics, glycomics, and bioinformatics analysis services, Creative Proteomics has introduced its newly-updated service--targeted metabolomics to assist biotech researchers of their clients
Nov 20, 2019
-
Accumen Launches New Website to Showcase Its Expanded Range of Technologies and Services to Optimize Healthcare Performance
PHOENIX, AZ - Nov 20, 2019 - Accumen Inc., the leader in healthcare performance, today announced the launch of its new website at www
Nov 20, 2019
-
Mologic launches clinical trial for validation of point-of-care COPD exacerbation alert system
BEDFORDSHIRE, UNITED KINGDOM - Nov 20, 2019 -
- COPE-WEL study aims to validate Headstart® test for early detection and monitoring of pulmonary exacerbation of COPD
- Headstart is a non-invasive self-test that detects lung biomarkers in the urine
- Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres
-
Optibrium collaborates with Enamine and BioSolveIT to add REAL Space Search Tool to StarDrop
CAMBRIDGE, UNITED KINGDOM - Nov 19, 2019 - Optibrium, BioSolveIT and Enamine, leading providers of software and services for drug discovery, today announce a three-way collaboration enabling efficient search of Enamines REAL Space directly from within Optibriums StarDrop software
Nov 20, 2019
-
Creative Biolabs Announced cd25 Monoclonal Antibody for Research Use
SHIRLEY, NY - Nov 19, 2019 - November 19, 2019, as a leading supplier in the recombinant antibody field, Creative Biolabs aims to provide high-quality services and products to clients in the academia and industry fields all over the world
Nov 18, 2019
-
ScaleMatrix’ DDC Technology Enables Enterprises to Deploy 13 PFLOP NVIDIA DGX-powered ‘AI Anywhere’ Infrastructure with Flexible, ‘No Data Center Required’ Design
DENVER, CO - Nov 18, 2019 - ScaleMatrix, through its subsidiary company, DDC, the global leader in providing scalable data center-to-edge solutions based on its patented Dynamic Density Control™ (DDC) cabinet technology, today announced that it is collaborating with NVIDIA and Microway to deliver SKUs for an 8 petaFLOPS and a 13 petaFLOPS 'Supercomputer Anywhere' solution using its DDC S-Series cabinetsx
Nov 18, 2019
-
Greenphire Demonstrates Continued Commitment to Global Sponsors and Sites; Participates in Two Leading European Clinical Trial Conferences and Hosts User Group in Poland
KING OF PRUSSIA, PA, UNITED STATES - Nov 18, 2019 - Greenphire, the global leader in financial workflow automation solutions for clinical trials, today announced its company executives will present at two of Europe's most important clinical trial conferences, the Central & Eastern European Site Symposium in Warsaw, Poland on Monday, November 18 and Clinical Trials Europe, in Barcelona, Spain on Thursday, November 21
Nov 18, 2019
-
Life Image and Graticule Launch GLIMPS in the New AWS Data Exchange
NEWTON, MA, UNITED STATES - Nov 18, 2019 - Life Image, one of the worlds largest medical evidence networks for clinical and imaging data, and its strategic partner, Graticule, an advanced real world data firm, announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange, a new service that makes it easy for millions of Amazon Web Services (AWS) customers to securely find, subscribe to, and use third-party data in the cloud
Nov 18, 2019
-
Montrium Releases Office 365 Compliance Toolkits to Accelerate Transition to Cloud for the Life Sciences
MONTREAL, QC, CANADA - Nov 20, 2019 - Montrium, an experienced and trusted technology consulting company for the life sciences industry, today announced the launch of a series of comprehensive service Toolkits to support migrating and managing regulated content in Microsofts Office 365 platform
Nov 18, 2019
-
Survey Findings Show Increase in Clinical Trial Results Transparency
JERSEY CITY, NJ, UNITED STATES - Nov 15, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has released results from its 2nd Biennial Plain Language Summaries (PLS) Survey
Nov 15, 2019
-
Lifebit and Medley Genomics Partner to Deliver Streamlined Solution Supporting New Diagnostic and Therapeutic Discoveries
LONDON, UK - Nov 14, 2019 -
Nov 14, 2019
Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, and Medley Genomics, a company focused on using advanced data analytics to support better diagnosis and treatment of complex diseases, announced today their partnership agreement
-
Creative Diagnostics Introduces New Foodborne Pathogen Antibodies and Antigens
SHIRLEY, NY, UNITED STATES - Nov 14, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics launches a large range of foodborne pathogen antibodies and antigens, which have been validated to work in various types of immunoassays and can be supplied as high quality tools for the detection of foodborne pathogens
Nov 13, 2019